UC Irvine awarded $18 million to lead groundbreaking dementia study - Summary - MDSpire

UC Irvine awarded $18 million to lead groundbreaking dementia study

  • By

  • October 7, 2025

  • 1 min

Share

Objective:

To lead a multi-center study on limbic predominant age-related TDP-43 encephalopathy (LATE), a neurodegenerative disease that stems from a distinct pathology compared to Alzheimer's.

Key Findings:
  • LATE is present in up to 40% of older adults and lacks reliable diagnostic tools, often being misdiagnosed as Alzheimer's.
  • The study aims to improve understanding and diagnosis of LATE.
Interpretation:

This research is critical for developing diagnostic tools for LATE, which is often misdiagnosed as Alzheimer's due to similar symptoms, highlighting the urgency of this work.

Limitations:
  • The study is limited to participants aged 85 and older.
  • Findings may not be generalizable to younger populations or those with different health conditions.
Conclusion:

The grant reinforces UC Irvine's leadership in dementia research, including a recent $21 million renewal for its Alzheimer’s Disease Research Center, and its commitment to improving brain health across diverse populations.

Original Source(s)

Related Content